Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: lapatinib ditosylate|DRUG: paclitaxel albumin-stabilized nanoparticle formulation
Sponsor: Northwestern University
Collaborators: GlaxoSmithKline|Celgene Corporation